Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144:1941–53.

Article  CAS  PubMed  Google Scholar 

Yang L, Yuan Y, Zhu R, Zhang X. Time trend of global uterine cancer burden: an age-period-cohort analysis from 1990 to 2019 and predictions in a 25-year period. BMC Womens Health. 2023;23:384.

Article  PubMed  PubMed Central  Google Scholar 

Lee SJ, Schover LR, Partridge AH, Patrizio P, Wallace WH, Hagerty K, et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol. 2006;24:2917–31.

Article  PubMed  Google Scholar 

Quinn GP, Vadaparampil ST, Gwede CK, Miree C, King LM, Clayton HB, et al. Discussion of fertility preservation with newly diagnosed patients: oncologists’ views. J Cancer Surviv. 2007;1:146–55.

Article  PubMed  Google Scholar 

Fertility preservation and reproduction in patients facing gonadotoxic therapies: a committee opinion. Fertil Steril. 2013;100:1224–31.

ICO/IARC HPV Information Centre. Human Papillomavirus and Related Diseases Report 2023–03–10. https://hpvcentre.net/statistics/reports/CHN.pdf.

Reade CJ, Eiriksson LR, Covens A. Surgery for early stage cervical cancer: how radical should it be? Gynecol Oncol. 2013;131:222–30.

Article  PubMed  Google Scholar 

Liu Y, Huang L. Fertility protection in patients with gynecologic malignancies. J Qingdao Med Health. 2024;56:145–8.

Ota T, Yoshida M, Kimura M, Kinoshita K. Clinicopathologic study of uterine endometrial carcinoma in young women aged 40 years and younger. Int J Gynecol Cancer. 2005;15:657–62.

Article  CAS  PubMed  Google Scholar 

Duska LR, Garrett A, Rueda BR, Haas J, Chang Y, Fuller AF. Endometrial cancer in women 40 years old or younger. Gynecol Oncol. 2001;83:388–93.

Article  CAS  PubMed  Google Scholar 

Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69:7–34.

You Y, Yang Q. Fertility-preserving treatment modalities for endometrial cancer. J Pract Obstet Gynecol. 2020;36:419–22.

Yang B, Xu Y, Zhu Q, Xie L, Shan W, Ning C, et al. Treatment efficiency of comprehensive hysteroscopic evaluation and lesion resection combined with progestin therapy in young women with endometrial atypical hyperplasia and endometrial cancer. Gynecol Oncol. 2019;153:55–62.

Article  CAS  PubMed  Google Scholar 

Crafton SM, Cohn DE, Llamocca EN, Louden E, Rhoades J, Felix AS. Fertility-sparing surgery and survival among reproductive-age women with epithelial ovarian cancer in 2 cancer registries. Cancer. 2020;126:1217–24.

Article  PubMed  Google Scholar 

Sun D, Fan JT, Zhang SQ, Wang JD, Wang YD. Chinese Expert Consensus on Fertility Preservation for Ovarian Malignancies (2022 Edition). J Chin J Pract Gynecol Obstet. 2022;38:705–13.

Torre LA, Trabert B, DeSantis CE, Miller KD, Samimi G, Runowicz CD, et al. Ovarian cancer statistics, 2018. CA Cancer J Clin. 2018;68:284–96.

Ray-Coquard I, Morice P, Lorusso D, Prat J, Oaknin A, Pautier P, et al. Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;29:iv1-iv18.

Shah JS, Guerra R, Bodurka DC, Sun CC, Chisholm GB, Woodard TL. Factors influencing fertility-sparing treatment for gynecologic malignancies: a survey of Society of Gynecologic Oncology members. Gynecol Oncol. 2017;147:497–502.

Article  PubMed  Google Scholar 

Wang W, Wang XG, Liu SJ, Wang YD, Xiang Y, Wang JD, et al. Chinese Expert Consensus on the Diagnosis and Treatment of Borderline Ovarian Tumors (2022 Edition). J Chin J Pract Gynecol Obstet. 2022;38:1185–94.

Yao TT, Fu ZJ, Lin ZQ. Fertility preservation in patients with vulvar cancer and vaginal malignancy. J Chin J Pract Gynecol Obstet. 2022;38:1063–7.

Jhingran A. Updates in the treatment of vaginal cancer. Int J Gynecol Cancer. 2022;32:344–51.

Article  PubMed  PubMed Central  Google Scholar 

Gadducci A, Lanfredini N, Cosio S. Reproductive outcomes after hydatiform mole and gestational trophoblastic neoplasia. Gynecol Endocrinol. 2015;31:673–8.

Article  PubMed  Google Scholar 

Jiang SY, Zhao. Research progress in fertility-preserving therapy for gestational trophoblastic tumors. 2020;12:149–54. https://doi.org/10.3969/j.issn.1674-5671.2020.02.07.

Wang FF, Cheng XD. Fertility-preserving treatment strategies for gestational trophoblastic tumors. J Chin J Clin. 2020;48:408–12.

Xi L, Sun Y. Gestational trophoblastic tumor fertility preservation strategies. 2022;38:701-4. https://doi.org/10.19538/j.fk2022070109.

Dicken CL, Lieman HJ, Dayal AK, Mutyala S, Einstein MH. A multidisciplinary approach to fertility-sparing therapy for a rare vulvar tumor. Fertil Steril. 2010;93(267):e5-7.

Google Scholar 

Wo JY, Viswanathan AN. Impact of radiotherapy on fertility, pregnancy, and neonatal outcomes in female cancer patients. Int J Radiat Oncol Biol Phys. 2009;73:1304–12.

Article  PubMed  PubMed Central  Google Scholar 

Ma XX, Xiang Y, Di W, Zhang SQ, Zhang GN, Guo RX, et al. Chinese Expert Consensus on Ovarian Transfer Before Radiotherapy for Pelvic Malignant Tumors (2023 Edition). J Chi J Pract Gynecol Obstet. 2023;39:1114–8.

Liang XY, Fang C, Li JJ, Li TT, Li ZM, Xie XM, et al. Expert consensus on fertility preservation and preservation of female cancer patients in China. Clin Oncol China. 2020;47:217–21.

Google Scholar 

Detti L. Options for preserving fertility in women undergoing gonadotoxic treatment. Clevel Clin J Med. 2021;88:607–12.

Article  Google Scholar 

Phelippeau J, Cazalis CG, Koskas M. Ovarian protection and fertility preservation in women with cancer: a French national registry analysis between 2005 and 2014. J Gynecol Obstet Hum Reprod. 2019;48:705–10.

Article  PubMed  Google Scholar 

Cho HW, Lee S, Min KJ, Hong JH, Song JY, Lee JK, et al. Advances in the treatment and prevention of chemotherapy-induced ovarian toxicity. Int J Mol Sci. 2020;21. https://doi.org/10.3390/ijms21207792

Spears N, Lopes F, Stefansdottir A, Rossi V, De Felici M, Anderson RA, et al. Ovarian damage from chemotherapy and current approaches to its protection. Hum Reprod Update. 2019;25:673–93.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kim S, Kim SW, Han SJ, Lee S, Park HT, Song JY, et al. Molecular mechanism and prevention strategy of chemotherapy- and radiotherapy-induced ovarian damage. Int J Mol Sci. 2021;22. https://doi.org/10.3390/ijms22147484.

Kim S, Lee S, Park HT, Song JY, Kim T. Genomic consideration in chemotherapy-induced ovarian damage and fertility preservation. Genes. 2021;12. https://doi.org/10.3390/genes12101525.

Sellami I, Beau I, Sonigo C. Chemotherapy and female fertility. Ann Endocrinol. 2023;84:382–7.

Article  Google Scholar 

Di Tucci C, Galati G, Mattei G, Chinè A, Fracassi A, Muzii L. Fertility after cancer: risks and successes. Cancers. 2022;14. https://doi.org/10.3390/cancers14102500.

Sonmezer M, Oktay K. Fertility preservation in young women undergoing breast cancer therapy. Oncologist. 2006;11:422–34.

Article  CAS  PubMed  Google Scholar 

Soo-Hoo S, Luesley D. Vulval and vaginal cancer in pregnancy. Best Pract Res Clin Obstet Gynaecol. 2016;33:73–8.

Article  PubMed  Google Scholar 

Xiong J, Xue L, Li Y, Tang W, Chen D, Zhang J, et al. Therapy of endocrine disease: novel protection and treatment strategies for chemotherapy-associated ovarian damage. Eur J Endocrinol. 2021;184:R177–92.

Article  CAS  PubMed  Google Scholar 

Chen H, Xiao L, Li J, Cui L, Huang W. Adjuvant gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in premenopausal women. Cochrane Database Syst Rev. 2019;3:Cd008018.

Fu ZJ, Li XD. Mechanism of chemotherapy drugs on ovarian function and fertility protection. Chin J Reprod Contracept. 2018;38:4.

Google Scholar 

Wang J. Expert consensus on the prevention and treatment strategies of ovarian injury during chemotherapy in female patients with malignant tumors. J Pract Obstet Gynecol. 2020;36:4.

Google Scholar 

Hatirnaz Ş, Hatirnaz E, Urkmez SS, Celik S, Urkmez YC, Cao M, et al. Comparison of luteal phase and follicular phase in-vitro maturation in women with oocyte maturation abnormalities. Reprod Biomed Online. 2024;48:103648.

Article  PubMed  Google Scholar 

Lv AX, Jin HX. Role of cumulus cells in vitrification cryopreservation of immature oocytes. J Int J Reprod Health/Fam Plann. 2017;36:313–7.

Liang XY, Fang C, Li JJ, Li TT, Li ZM, Xie XM, et al. Expert consensus on fertility protection and preservation of Chinese female tumor patients. J China Cancer Clin. 2020;47:217–21.

Tian L, Wang JL. Status of in vitro fertilization based female fertility conservation technology. J Pract J Obstet Gynecol. 2020;36:245–7.

Consensus of Chinese experts on ovarian tissue cryopreservation and transplantation. J Chin J Clin. 2018;46:496–500.

Zhang YY, Gao R, Chen HX, Qin L. Review of research progress in ovarian tissue cryopreservation and transplantation. J Contemp Med. 2020;26:189–91.

Corkum KS, Rhee DS, Wafford QE, Demeestere I, Dasgupta R, Baertschiger R, et al. Fertility and hormone preservation and restoration for female children and adolescents receiving gonadotoxic cancer treatments: a systematic review. J Pediatr Surg. 2019;54:2200–9.

Article  PubMed  Google Scholar 

Dittrich R, Lotz L. Fertility and fertility preservation in women. Dermatologie (Heidelberg, Germany). 2023;74:481–9.

PubMed  Google Scholar 

Lan JF, Chen XJ, Ding JX, Chen QH, Pan LY, Wang YX. Chinese expert consensus on fertility protection and preservation of ovarian non benign tumors (2023 Edition). J Chin J Pract Gynecol Obstet. 2023;39:809–16.